Music and NPR News for Central and Northern Michigan
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Health, Science and Environment

Grand River Aseptic Manufacturing filling Johnson & Johnson COVID-19 vials

3540093871_5ae0acd368_b.jpg
"2 ml serum vials" by savard.photo is licensed with CC BY-NC-ND 2.0. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-nd/2.0/
/

The U.S. now has a third vaccine preventing COVID-19. The Johnson & Johnson vaccine approved by the Food and Drug Administration over the weekend is manufactured in Grand Rapids.

“It’s great news for, you know, our country. Great news for the world. And it’s certainly great news for West Michigan.”

From its state-of-the-art Grand Rapids-based facility, Grand River Aseptic Manufacturing is filling the Johnson & Johnson COVID-19 vaccine. Selected in August by Operation Warp Speed, the two were paired and a deal finalized in September. Tom Ross is GRAM President and CEO.

“We’ve been planning and developing this since we signed the contract last fall. So, we’ve been manufacturing for a few months now and we’re continuing to manufacture today and in the future.”

Four million doses expedited Monday. J&J says it will deliver about 16 million more doses by the end of March.

“The vaccine is produced here and we do formulation activities, some dilution steps, some sterilization steps with filters and sterile filling into the vials.”

Steve Nole is Vice President of Operations.

“So, what you see in the marketplace as a vial with fill product that’s what we produce here.”

GRAM’s team has worked tirelessly meeting demand. Over the past six months it added 125 employees. The plan is to hire another 75 this year. It’s also adding capacity. In late spring GRAM is opening a new 110,000 square foot finishing center near the Gerald R. Ford International Airport.